The portable air disinfection device has been registered on China’s National Online Record Information Service Platform for Disinfection Products.
Dublin, Ireland, 16 March 2020 – China’s National Online Record Information Service Platform for Disinfection Products has recently registered the Defend 1050, Novaerus’ all-in-one air disinfection and purification device. The National Platform recognizes products it deems suitable for disinfection in healthcare facilities nationwide, with all products independently tested to ensure compliance with national hygiene standards.
The Defend 1050 is a medical-grade, portable device that uses a combination of plasma and filter technology to safely disinfect and purify indoor air, supplementing surface and hand hygiene for comprehensive infection control. The efficacy of the device was tested and qualified by the Guangzhou Institute of Microbiology.
The recognition is welcomed at a time when clean, disinfected air is thought to play an important role in preventing the spread of COVID-19. Recently, aerosol transmission was added to the diagnosis and treatment plan issued by the National Health Commission and National Administration of Traditional Chinese Medicine as a possible route of coronavirus (COVID-19) infection. This suggests that the virus is not only transmitted via airborne respiratory droplets but also via aerosols that can remain suspended in the air for long periods and can be inhaled.
Novaerus portable air dis-infection devices use a non-selective, rapid killing, patented plasma technology, offering a unique and safe solution to kill airborne viruses 24/7. The technology has been independently tested to reduce MS2 Bacteriophage, a commonly used surrogate for SARS-CoV* (Coronavirus) by 99.99%.
The Defend 1050’s registration is an important step for Novaerus, as they expand their distribution network in China, providing health facilities across the country access to Novaerus patented clean air technology. Recently, the company donated several air dis-infection devices to hospitals in Wuhan, the city at the centre of the COVID-19 outbreak, to help them reinforce their virus protection protocols.
Novaerus is part of WellAir, an Irish company on a mission to reduce indoor airborne pollutants to create living, working, and healing spaces that foster rather than detract from human health, productivity, and wellbeing. WellAir and its brands, Novaerus and Plasma Air, can be found installed in hundreds of hospitals, senior living facilities, schools, casinos, railway stations, residences, and industrial facilities in more than 40 countries around the world.
For more information visit www.novaerus.com.
*(2010 – Evaluation of filters for the sampling and quantification of RNA Phage Aerosols, Louis Gendron et al.)